Gainers
- Arcturus Therapeutics ARCT stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's stock is trading at a volume of 4.1 million, which is 818.75% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.
- Translate Bio TBIO stock increased by 29.02% to $37.61. Trading volume for Translate Bio's stock is 42.0 million as of 12:35 EST. This is 4465.9% of its average full-day volume over the last 100 days. The company's market cap stands at $2.8 billion.
- Applied DNA Sciences APDN shares increased by 27.25% to $6.91. The current volume of 2.2 million shares is 357.67% of Applied DNA Sciences's average full-day volume over the last 100 days (last updated at 12:35 EST). The company's market cap stands at $51.7 million.
- NeuroMetrix NURO shares rose 20.46% to $15.8. The current volume of 3.8 million shares is 50.25% of NeuroMetrix's average full-day volume over the last 100 days (last updated at 12:35 EST). The market value of their outstanding shares is at $88.9 million.
- Outlook Therapeutics OTLK shares rose 16.37% to $2.63. As of 12:35 EST, this security is trading at a volume of 94.0 million shares, making up 10449.3% of its average full-day volume over the last 100 days. The company's market cap stands at $456.6 million.
- ATI Physical Therapy ATIP shares moved upwards by 13.59% to $4.26. Trading volume for ATI Physical Therapy's stock is 5.7 million as of 12:35 EST. This is 223.97% of its average full-day volume over the last 100 days. The company's market cap stands at $883.0 million.
Losers
- Neuronetics STIM stock decreased by 40.87% to $7.71 during Tuesday's regular session. Neuronetics's stock is trading at a volume of 3.1 million shares as of 12:35 EST. This is 653.26% of its average full-day volume over the last 100 days. The company's market cap stands at $198.4 million. As per the news, the Q2 earnings report came out today.
- Kiniksa Pharmaceuticals KNSA stock decreased by 21.48% to $12.74. Trading volume for Kiniksa Pharmaceuticals's stock is 1.5 million as of 12:35 EST. This is 370.73% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $870.8 million. As per the news, the Q2 earnings report came out today.
- Scholar Rock Holding SRRK shares fell 17.54% to $28.32. As of 12:35 EST, this security is trading at a volume of 323.6K shares, making up 124.01% of its average full-day volume over the last 100 days. The company's market cap stands at $974.6 million.
- SeaSpine Holdings SPNE shares fell 15.61% to $16.77. The current volume of 317.9K shares is 180.19% of SeaSpine Holdings's average full-day volume over the last 100 days (last updated at 12:35 EST). The market value of their outstanding shares is at $556.1 million. As per the press release, Q2 earnings came out yesterday.
- SI-BONE SIBN stock decreased by 15.07% to $25.7. Trading volume for SI-BONE's stock is 689.9K as of 12:35 EST. This is 278.07% of its average full-day volume over the last 100 days. The company's market cap stands at $843.7 million. As per the news, the Q2 earnings report came out yesterday.
- Infinity Pharmaceuticals INFI shares decreased by 13.49% to $2.54. As of 12:35 EST, Infinity Pharmaceuticals's stock is trading at a volume of 9.7 million, which is 153.79% of its average full-day volume over the last 100 days. The company's market cap stands at $224.9 million.
APDNApplied DNA Sciences Inc
$5.427.33%
Edge Rankings
Momentum
0.26
Growth
20.28
Quality
N/A
Value
96.49
Price Trend
Short
Medium
Long
ARCTArcturus Therapeutics Holdings Inc
$13.873.82%
ATIPATI Physical Therapy Inc
$1.03-42.5%
KNSAKiniksa Pharmaceuticals International PLC
$27.95-%
OTLKOutlook Therapeutics Inc
$1.880.81%
SIBNSI-BONE Inc
$18.150.75%
SRRKScholar Rock Holding Corp
$34.24-3.49%
STIMNeuronetics Inc
$3.411.19%
TBIOTelesis Bio Inc
$0.3000-90.7%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.